Mimura H, Mori M, Hamazaki K, Tsuge H
First Department of Surgery, Okayama University Medical School, Japan.
Hepatogastroenterology. 1994 Oct;41(5):483-8.
Hepatic carcinoma recurrence in the early months after pancreatectomy for ductal carcinoma of the head of the pancreas is one of the major factors of the poor survival rate. Early hepatic recurrence might be caused by carcinoma cells entering the portal vein as a result of surgical manipulations. To deal with this problem, we devised a new operative procedure called "isolated pancreatectomy" in 1987. This method involves no-touch pancreatic resection combined with extensive retroperitoneal skeletonization. Both the feeding and draining vessels of the pancreatic carcinoma are ligated and divided prior to pancreatectomy. The confluence of the portal vein, the superior mesenteric vein, and the splenic vein is removed together with the pancreatic head. The wide surgical field thus obtained facilitates subsequent skeletonization of the retroperitoneum. We have experienced 71 cases of pancreatectomy for ductal carcinoma of the head of the pancreas among whom isolated pancreatectomy has been performed in 16 patients since 1987. In all cases, long-term survival was obtained in the patients undergoing curative and extended resection. The cumulative five-year survival rate for stages I and II was 40.7%, and that for stage III was 17.3%. After the introduction of isolated pancreatectomy, hepatic recurrence rates within six months and 12 months after pancreatectomy have dropped to 0% and 16.7%, respectively, from the 22.9% and 31.3% of the other pancreatectomy. The survival rate for the patients with stage III in isolated pancreatectomy significantly exceeded that obtained with other pancreatectomy.
胰头导管癌胰十二指肠切除术后早期出现肝癌复发是生存率低的主要因素之一。早期肝复发可能是由于手术操作导致癌细胞进入门静脉所致。为解决这一问题,我们于1987年设计了一种新的手术方法,称为“孤立性胰十二指肠切除术”。该方法包括非接触性胰腺切除联合广泛的腹膜后骨骼化。在胰十二指肠切除术前结扎并切断胰腺癌的供血和引流血管。将门静脉、肠系膜上静脉和脾静脉的汇合处与胰头一并切除。由此获得的广阔手术视野便于后续的腹膜后骨骼化操作。自1987年以来,我们共收治了71例胰头导管癌患者并施行了胰十二指肠切除术,其中16例患者接受了孤立性胰十二指肠切除术。所有接受根治性和扩大切除术的患者均获得了长期生存。Ⅰ期和Ⅱ期患者的累计五年生存率为40.7%,Ⅲ期患者为17.3%。采用孤立性胰十二指肠切除术后,胰十二指肠切除术后6个月和12个月的肝复发率分别从其他胰十二指肠切除术的22.9%和31.3%降至0%和16.7%。孤立性胰十二指肠切除术中Ⅲ期患者的生存率显著高于其他胰十二指肠切除术。